Cable Hill Partners, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Cable Hill Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 20, 2018	SELL	$7.86 - $11.39 $1,572 - $2,278	-200 Closed	0 $0
Q4 2017 Feb 22, 2018	SELL	$8.77 - $12.28 $2,885 - $4,040	-329 Reduced 62.19%	200 $2,000
Q3 2017 Oct 27, 2017	SELL	$12.17 - $16.3 $158 - $211	-13 Reduced 2.4%	529 $7,000
Q2 2017 Aug 14, 2017	BUY	N/A	542	542 $9,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $162M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.